Cree, B A C <br/><br/>
An open label study of the effects of rituximab in neuromyelitis optica.  [electronic resource] 

 -  Neurology  Apr 2005 
 - 1270-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.WNL.0000159399.81861.D5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>B-Lymphocytes--drug effects<br/>Disability Evaluation<br/>Female<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Lymphocyte Count<br/>Male<br/>Myelitis, Transverse--drug therapy<br/>Neuromyelitis Optica--drug therapy<br/>Optic Nerve--drug effects<br/>Optic Neuritis--drug therapy<br/>Recovery of Function--drug effects<br/>Rituximab<br/>Secondary Prevention<br/>Spinal Cord--drug effects<br/>Treatment Outcome